G-{d-Arg}-GDSPASSK

Send Inquiry
G-{d-Arg}-GDSPASSK
Details
•Product Name: G-{d-Arg}-GDSPASSK (D-arginine-modified fibronectin anti-adhesion nonapeptide)
•CAS No.: 133640-14-9
•Sequence: Gly-{D-Arg}-Gly-Asp-Ser-Pro-Ala-Ser-Ser-Lys (G-dArg-GDSPASSK)
•Length: 9 amino acids
•Molecular Formula: C37H64N14O16
•Molecular Weight: 960.99 Da
•Origin: Synthetic (fibronectin RGD-related sequence with D-configured arginine at position 2)
•Purity: HPLC≥95%
Related Docs: COA/MS/HPLC Report, Peptide Solubility and Storage Guide
Category
Cell Adhesion Peptides
Share to
Description

Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of g-{d-arg}-gdspassk in China, also supports custom service. Welcome to wholesale bulk high quality g-{d-arg}-gdspassk from our factory. Contact us for more details.

 

Description G-{d-Arg}-GDSPASSK (CAS: 133640-14-9) is a fibronectin-derived nonapeptide, sequence Gly-{D-Arg}-Gly-Asp-Ser-Pro-Ala-Ser-Ser-Lys with D-arginine at position 2, molecular formula C37H64N14O16, MW 960.99 Da. The D-amino acid confers resistance to enzymatic degradation, enhancing in vivo stability. The peptide inhibits cell adhesion, thereby promoting wound healing and tissue repair; it is also used to study fibronectin-receptor-mediated signal transduction (e.g., collagenase and stromelysin gene expression) and the impact of D-amino-acid modification on peptide pharmacokinetics.
Structure type Linear 9-mer (D-Arg at position 2, fibronectin anti-adhesion sequence)
Solubility Readily soluble in water, PBS buffer
Storage Powder -20C, dry, protected from light

 

Product Basic Information Table

 

Product Standard English Name Product Abbreviation / Alias Function Tags (comma-separated) Core Structure Molecular Formula Exact Mass (Da) Average MW (Da) Salt Form Length (aa)
Gly-{D-Arg}-GDSPASSK (D-Arginine-substituted RGD mimetic decapeptide, protease-resistant integrin ligand) Gly-D-Arg-Gly-Asp-Ser-Pro-Ala-Ser-Ser-Lys; GRGDSPASSK (D-Arg2); D-Arg RGD mimetic; G-{d-Arg}-GDSPASSK; CAS 133640-14-9; protease-resistant RGD peptide; Note: originally cited CAS 133640-94-0 was not found in databases; verified CAS is 133640-14-9 cell adhesion, fibronectin, RGD motif, integrin ligand, D-amino acid, protease-resistant, long half-life, αvβ3, α5β1, integrin inhibitor, wound healing, tissue repair Linear decapeptide, sequence H-Gly-{D-Arg}-Gly-Asp-Ser-Pro-Ala-Ser-Ser-Lys-OH (G-{D-R}-G-D-S-P-A-S-S-K); position 2 is D-arginine, all other residues are L-amino acids; contains the RGD (Arg-Gly-Asp) integrin-binding core motif, but the Arg is in D-configuration; D-Arg has the identical molecular formula as L-Arg (C6H14N4O2), differing only in stereochemistry; side-chain net charge +1 (D-Arg +1, Lys +1, Asp -1); N-terminal +1 and C-terminal -1 cancel out, giving overall net charge ~+1; hydrophobic residues 20% (Pro×1, Ala×1, total 2/10); no Cys (no disulfide), no Met (no oxidation), no Trp (no photo-oxidation); KEY FEATURE: contains a D-amino acid, conferring resistance to protease degradation (aminopeptidases, carboxypeptidases), resulting in a significantly longer in-vivo half-life compared to all-L RGD analogs C37H64N14O16 960.46 961.00 Free base, powder; CAS 133640-14-9; D-Arg is a non-natural amino acid substitution conferring protease resistance 10

 

Physicochemical Solubility & Storage Parameters

 

Product Code Appearance Long-term Storage Short-term Storage Solution Stability Solid Powder Stability
PEP-DRGDSP-01 White to off-white powder Store at -20°C, sealed, dry, protected from light (~2–3 years). Aliquot to avoid repeated freeze-thaw. Contains a D-amino acid-superior in-vivo stability vs all-L peptides. No Met/Cys/Trp-low oxidation risk. 2–8°C for up to ~1 month; working aliquots at -20°C. Stable for shipping at ambient temperature. Small linear peptide with good water solubility (aqueous buffer ≥3–5 mg/mL; may use a small amount of DMSO or dilute acetic acid to aid dissolution). Contains one acidic Asp side chain and basic D-Arg/Lys side chains, overall net charge ~+1. No Cys (no disulfide), no Met (no oxidation), no Trp (no photo-oxidation). Because it contains a D-amino acid, it exhibits significant resistance to serum/tissue proteases and has superior solution-phase stability compared to all-L RGD peptides. Weigh quickly after opening and reseal. solid stable for ~2–3 years at -20°C, sealed and dry. Moderate hygroscopicity-store in a desiccator.

 

Functional Description

 

Product Code Frontend Short Summary Detailed Biological Function Description Applicable Research Areas (comma-separated) Targets / Pathways
PEP-DRGDSP-01 A D-arginine-substituted RGD decapeptide integrin ligand analog that retains RGD integrin-binding activity. The D-amino acid confers protease resistance and a longer in-vivo half-life, making it suitable for prolonged integrin inhibition in cell adhesion, wound healing, and tissue repair research. This is a D-arginine-substituted analog of RGDSPASSK, with the sequence Gly-D-Arg-Gly-Asp-Ser-Pro-Ala-Ser-Ser-Lys. The Arg within the core RGD (Arg-Gly-Asp) motif is in the D-configuration, while all other residues are natural L-amino acids. D-amino acid substitution is a classic strategy in peptide drug design to extend in-vivo half-life: proteases are strictly stereoselective for L-amino acid substrates, and a D-amino acid residue resists hydrolysis by aminopeptidases, carboxypeptidases, and endopeptidases, thereby markedly improving peptide stability in serum and in-vivo environments. This peptide retains RGD-motif binding to integrins (αvβ3, α5β1, etc.) and competitively inhibits cell adhesion to fibronectin. Literature reports that this D-Arg analog inhibits cell adhesion and facilitates wound healing and tissue repair. Compared with all-L RGD peptides, this analog has a more prolonged effect in vivo and is suitable for scenarios requiring sustained integrin antagonism, such as wound repair, anti-inflammation, and anti-metastasis research. Cell adhesion, integrin biology, D-amino acid peptide, protease-resistant long-acting peptide, wound healing, tissue repair, inflammation, tumor metastasis, peptide drug development αvβ3, α5β1 and other RGD-dependent integrins; fibronectin-integrin adhesion interface; protease resistance (aminopeptidases/carboxypeptidases/endopeptidases); cell migration and FAK signaling pathway

 

 

 

 

Hot Tags: g-{d-arg}-gdspassk, China g-{d-arg}-gdspassk manufacturers, suppliers, factory, 239075-62-8, 91575-26-7, CAS 239075 62 8, CAS 93674 95 4, CAS 93675 01 5, EILEVPST

Send Inquiry